- Country: South Korea
- Summary: Corona 19 Variance and Drug Therapy Assessment in Controlled and Mids
- KRT Ref No: 54877860
- Deadline: 16 Jul 2021
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: KRW 300000000
- Notice Type: Tender
- Document Ref. No.: 20210704119-00
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Corona 19 Variable Virus Infection and Drug Therapy Evaluation in Contrast and Mids Reference Number: Disease Administration National Health Research Institute Notification No. 2021-159
Budget: 330,000,000 won
Estimated price: 300,000,000 won
Bidding start: 2021/07/09 10:00:00:00
Bidding Finish: 2021/07/16 10:00:00 - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINCorona 19 Variance and Drug Therapy Assessment in Controlled and Mids - Korea Tender
The NATIONAL HEALTH RESEARCH INSTITUTE OF DISEASE ADMINISTRATION, a Government sector organization in South Korea, has announced a new tender for Corona 19 Variance and Drug Therapy Assessment in Controlled and Mids. This tender is published on KoreaTenders under KRT Ref No: 54877860 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2021-07-16.
The estimated tender value is KRW 300000000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
